Merck signs licensing deals with companies including Viatris for new HIV pill
Merck signs licensing deals with companies including Viatris for new HIV pill Seeking Alpha
Covered in this story
What has happened since
- Viatris is up 6.7% since this was published, 88 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $VTRS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Viatris →Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.